- Home
- VGM vs PAHC Comparison
VGM vs PAHC Comparison
Compare VGM & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGM
- PAHC
- Stock Information
- Founded
- VGM 1992
- PAHC 1946
- Country
- VGM United States
- PAHC United States
- Employees
- VGM N/A
- PAHC N/A
- Industry
- VGM Trusts Except Educational Religious and Charitable
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- VGM Finance
- PAHC Health Care
- Exchange
- VGM Nasdaq
- PAHC Nasdaq
- Market Cap
- VGM 568.9M
- PAHC 682.5M
- IPO Year
- VGM N/A
- PAHC 2014
- Fundamental
- Price
- VGM $10.37
- PAHC $24.18
- Analyst Decision
- VGM
- PAHC Sell
- Analyst Count
- VGM 0
- PAHC 4
- Target Price
- VGM N/A
- PAHC $16.50
- AVG Volume (30 Days)
- VGM 186.2K
- PAHC 206.8K
- Earning Date
- VGM 01-01-0001
- PAHC 11-06-2024
- Dividend Yield
- VGM 4.34%
- PAHC 2.00%
- EPS Growth
- VGM N/A
- PAHC N/A
- EPS
- VGM 0.01
- PAHC 0.06
- Revenue
- VGM N/A
- PAHC $1,017,679,000.00
- Revenue This Year
- VGM N/A
- PAHC $15.85
- Revenue Next Year
- VGM N/A
- PAHC $11.79
- P/E Ratio
- VGM $988.00
- PAHC $403.24
- Revenue Growth
- VGM N/A
- PAHC 4.07
- 52 Week Low
- VGM $8.15
- PAHC $9.40
- 52 Week High
- VGM $10.07
- PAHC $25.11
- Technical
- Relative Strength Index (RSI)
- VGM 43.33
- PAHC 63.18
- Support Level
- VGM $10.40
- PAHC $23.59
- Resistance Level
- VGM $10.52
- PAHC $25.11
- Average True Range (ATR)
- VGM 0.05
- PAHC 0.80
- MACD
- VGM -0.01
- PAHC 0.08
- Stochastic Oscillator
- VGM 10.00
- PAHC 78.12
About VGM Invesco Trust for Investment Grade Municipals (DE)
Invesco Trust for Investment Grade Municipals is active in the financial services sector. Its investment objective is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.